Abstract
A variety of exogenous and endogenous agents, e.g., toxic compounds, drugs, pathogens, are responsible for acute and liver injuries which may lead to inflammation and fibrosis and impair hepatocyte functions. In inflamed and fibrotic livers, extracellular matrix remodelling is a complex mechanism of synthesis and degradation of matrix components, namely collagens, non-collagenous glycoproteins and proteoglycans. Fibrolysis is the result of the activation of proteases, among them matrix metalloproteinases, which cleave matrix components and release (poly)-peptide modules with specific biological activities. The dynamic turnover of extracellular matrix is regulated by cytokines and other soluble factors. Depicting these mechanisms opens the path to the identification of biomarkers and targeted drugs for the reversion of inflamed/fibrotic scar towards a normal architecture and the restoration of normal liver functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Guo J, Friedman SL (2007) Hepatic fibrogenesis. Semin Liver Dis 27: 413–426
Clement B, Levavasseur F, Loreal O, Lietard J, L’Helgoualc’h A, Guillouzo A (1993). Role of hepatocytes and Ito cells in the synthesis and deposition of extracellular matrix. In: C Surrenti, A Casini, S Milani, M Pinzani (eds): Fat-storing cells and liver fibrosis. Kluwer Academic Publishers, Dordrecht, 13–22
Benyon RC, Arthur MJ (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21: 373–384
Magness ST, Bataller R, Yang L, Brenner DA (2004) A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 40: 1151–1159
Rescan PY, Loreal O, Hassell JR, Yamada Y, Guillouzo A, Clement B (1993) Distribution and origin of the basement membrane comportent perlecan in rat liver and primary hepatocyte culture. Am J Pathol 142: 199–209
Musso O, Rehn M, Saarela J, Theret N, Lietard J, Hintikka E, Lotrian D, Campion JP, Pihlajaniemi T, Clement B (1998) Collagen XVIII is localized in sinusoids and basement membranes and expressed by hepatocytes and activated stellate cells in fibrotic human liver. Hepatology 28: 98–107
Clement B, Grimaud JA, Campion JP, Deugnier Y, Guillouzo A (1986) Cell types involved in the production of collagen and fibronectin in normal and fibrotic human liver. Hepatology 6: 225–234
Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337–23347
Roberston H, Kirby JA, Yip WW, Jones DE, Burt AD (2007) Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 45: 977–981
Iredale JP (1997) Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 29: 43–54
Aimes RT, Quigley JP (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J Biol Chem 270: 5872–5876
Elsharkawy AM, Oakley F, Mann DA (2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10: 927–939
Musso O, Theret N, Campion JP, Turlin B, Milani S, Grappone C, Clement B (1997) In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in primary hepatocellular carcinomas and in liver metastasis. J Hepatol 26: 593–605
Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, Calabro A, Ciancio G, Stefanini F et al (1994) Differential expression of matrix-metalloproteinase-1 and-2 genes in normal and fibrotic human liver. Am J Pathol 144: 528–537
Theret N, Musso O, L’Helgoualc’h A, Campion JP, Clement B (1998) Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MTMMPs) in association with MMP2 activation in injured human livers. Am J Pathol 153: 945–954
Theret N, Lehti K, Musso O, Clement B (1999) MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells. Hepatology 30: 462–468
Loreal O, Levavasseur F, Fromaget C, Gros D, Guillouzo A, Clement B (1993) Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro. Am J Pathol 143: 538–544
Le Pabic H, Bonnier D, Wewer UM, Coutand A, Musso O, Baffet G, Clement B, Theret N (2003) ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37: 1056–1066
Kesteloot F, Desmoulière A, Leclercq I, Thiry M, Arrese JE, Prockop DJ, Lapière CM, Nusgens BV, Colige A (2007) ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride-induced hepatic fibrosis in mice. Hepatology 46: 1620–1631
Wolfsberg TG, Primakoff P, Mykes DG, White JM (1995) ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multifunctionnl functions in cell-cell and cell-matrix interactions. J Cell Biol 131: 275–278
Flannery CR (2006) MMPs and ADAMTSs: functional studies. Front Biosci 11: 544–569
Mori S, Tanaka M, Nanba D, Nishiwaki E, Ishiguro H, Higashiyama S, Matsuura N (2003) PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J Biol Chem 278: 46029–46034
Le Pabic H, L’Helgoualc’h, Coutand A, Wewer UM, Baffet G, Clement B, Theret N (2005) Involvement of the serine/threonine p70S6 kinase in TGF-β1-induced ADAM12 expression in activated human hepatic stellate cells. J Hepatol 43: 1038–1044
Gressner AM (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: 793–807
Knittel T, Fellmer P, Ramadori G (1996) Gene expression and regulation of plasminogen activator type 1 in hepatic stellate cells of rat liver. Gastroenterology 111: 745–754
Vinas O, Bataller R, Sancho-Bru P, Ginès P, Berenguer C, Enrich C, Nicolás JM, Ercilla G, Gallart T, Vives J et al (2003) Human hepatic stellate cells show features of antigenpresenting cells and stimulate lymphocyte proliferation. Hepatology 38: 919–929
Corey EJ, Niwa N, Falck JR, Mioskowski C, Arai Y, Marfat A (1980) Recent studies on the chemical synthesis of eicosanoids. Adv Prostaglandin Thromboxane Res 6: 19–25
Decker K (1985) Eicosanoids, signal molecules of liver cells. Sem Liver Dis 5: 175–190
Ichiyama T, Kajimoto M, Hasegawa M, Hashimoto K, Matsubara T, Furukawa S (2007) Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages. Clin Exp Allergy 37: 608–614
Schenk S, Quaranta V (2003) Tales from the cryptic sites of the extracellular matrix. Trends Cell Biol 13: 366–375
Davis GE, Bayless KJ, Davis MJ, Meininger GA (2000) Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 156: 1489–1498
Vogel W, Gish GD, Alves F, Pawson T (1997) The discoidin domain receptor domain receptor tyrosine kinases are activated by collagen. Mol Cell 1: 13–23
Chelberg MK, McCarthy JB, Skubitz AP, Furcht LT, Tsilibary EC (1990) Characterization of a synthetic peptide from type IV collagen that promotes melanoma cell adhesion, spreading, and motility. J Cell Biol 111: 261–270
Rehn M, Pihlajaniemi T (1994) Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution and homology with type XV collagen (1994) Proc Natl Acad Sci USA 91: 4234–4238
Muragaki Y, Timmons S, Griffith CM, Oh SP, Fadel B, Quertermous T, Olsen BR (1995) Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc Natl Acad Sci USA 92: 8763–8767
Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T (1998) The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 153: 611–626
Lietard J, Theret N, Rehn M, Musso O, L’Helgoualc’h A, Dargere D, Pihlajaniemi T, Clement B (2000) The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements. Hepatology 32: 1377–1385
Musso O, Theret N, Heljasvaara R, Rehn M, Turlin B, Campion JP, Pihlajaniemi T, Clement B (2001) Tumor hepatocytes and basement membrane-producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancers. Hepatology 33: 868–876
Musso O, Rehn M, Theret N, Turlin B, Bioulac-Sage P, Lotrian D, Campion JP, Pihlajaniemi T, Clement B (2001) Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. Cancer Res 61: 45–49
Quelard D, Lavergne E, Hendaoui I, Elamaa H, Tiirola U, Heljasvaara R, Pihlajaniemi T, Clement B, Musso O (2008) A cryptic Frizzled module in cell-surface collagen 18 inhibits Wnt/β-catenin signaling. PLoS One 3: e1878
Kong HJ, Mooney DJ (2007) Micoenvironmental regulation of biomacromolecular therapies. Nat Rev Drug Discov 6: 455–463
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Clément, B. (2008). Extracellular matrix remodelling and matrix metalloproteinases in the liver. In: Lagente, V., Boichot, E. (eds) Matrix Metalloproteinases in Tissue Remodelling and Inflammation. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8585-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8585-9_9
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8584-2
Online ISBN: 978-3-7643-8585-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)